BrightSpring Health Services (BTSG) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
10 Apr, 2026Executive summary
Annual meeting scheduled for May 21, 2026, to be held virtually for stockholders of record as of March 30, 2026.
Proxy materials, including the Notice of Meeting, Proxy Statement, and Annual Report or Form 10-K, are available online, with paper copies available upon request.
Voting matters and shareholder proposals
Election of three Class II directors: Olivia Kirtley, Max Lin, and Steve Miller.
Ratification of KPMG LLP as the independent accounting firm for the year ending December 31, 2026.
Advisory vote on executive compensation (say-on-pay).
Board recommends a vote FOR all three proposals.
Board of directors and corporate governance
Board slate includes Olivia Kirtley, Max Lin, and Steve Miller for Class II director positions.
Partial view of Summaries dataset, powered by Quartr API
Latest events from BrightSpring Health Services
- Specialty pharmacy and integrated care drive robust growth, with expansion and M&A fueling outlook.BTSG
Goldman Sachs 47th Annual Global Healthcare Conference 202611 Jun 2026 - Integrated home health platform drives growth through scale, tech, and value-based care expansion.BTSG
46th Annual William Blair Growth Stock Conference3 Jun 2026 - Double-digit growth driven by integrated care, technology, and disciplined M&A strategy.BTSG
Investor Day 202618 May 2026 - Q1 2026 delivered 25.6% revenue growth, higher EBITDA, and improved leverage with raised guidance.BTSG
Q1 20261 May 2026 - Strong 2025 growth and double-digit 2026 gains expected, driven by acquisitions and efficiency.BTSG
Q4 202511 Apr 2026 - Director elections, auditor ratification, and executive pay are key focus areas for this annual meeting.BTSG
Proxy filing10 Apr 2026 - AI-driven efficiency, specialty growth, and strong provider performance fuel expansion and flexibility.BTSG
Leerink Global Healthcare Conference 202610 Mar 2026 - Strong growth, margin expansion, and strategic M&A drive positive outlook despite IRA headwinds.BTSG
TD Cowen 46th Annual Health Care Conference2 Mar 2026 - Q2 revenue up 26% to $2.73B, Adjusted EBITDA $139.1M, and guidance raised for 2024.BTSG
Q2 20242 Feb 2026